{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61958-3401",
      "generic_name": "LENACAPAVIR SODIUM",
      "labeler_name": "Gilead Sciences, Inc.",
      "brand_name": "Yeztugo",
      "active_ingredients": [
        {
          "name": "LENACAPAVIR SODIUM",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "61958-3401-1",
          "description": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1)",
          "marketing_start_date": "20250618",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Gilead Sciences, Inc."
        ],
        "rxcui": [
          "2625890",
          "2625904",
          "2625911",
          "2717197",
          "2717201",
          "2717203"
        ],
        "spl_set_id": [
          "1c241af1-ce62-4b0a-9eb7-f6b626174f01"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "BDT58WJ9WE"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "557388f0-4c3d-4fee-9bc8-72b035775b2e",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250618",
      "product_id": "61958-3401_557388f0-4c3d-4fee-9bc8-72b035775b2e",
      "application_number": "NDA220020",
      "brand_name_base": "Yeztugo",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "HIV Capsid Inhibitors [MoA]",
        "Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}